References
- Chertov O, Yang D, Howard OMZ, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177: 68–78.
- Mueller WEG, Blumbach B, Mueller IM. Evolution of the innate and adaptive immune systems: relationships between potential immune molecules in the lowest meta-zoan phylum (porifera) and those in vertebrates. Trans-plantation 1999; 68: 1215–27.
- Ganz T, Lehrer RI. Defensins. Pharmacol Ther 1995; 66: 191–205.
- Van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS. Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol 1999; 104: 1131–8.
- Bujia J, Schilling V, Holy A, Stammberger M, Kasten-bauer E. Hyperproliferation associated keratin expres-sion in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993; 113: 364–8.
- Sasaki M, Huang CC. Expression of cytokeratin 13 and 16 in middle ear cholesteatoma. Otolaryngol Head Neck Surg 1994; 110: 310–7.
- Bujia J, Holly A, Schilling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993; 103: 326–9.
- Kojima H, Shiwa M, Kamide Y, Moriyama H. Expres-sion and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol (Stockh) 1994; 114: 423–9.
- Bujia J, Sudhoff H, Holy A, Hildmann H. Immunohis-tochemical detection of proliferating cell nuclear anti-gen in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 1996; 253: 21–4.
- Park K, Chun YM, Lee DH, Hwang SC. Signal trans-duction pathway in human middle ear cholesteatoma. Otolaryngol Head Neck Surg 1999; 120: 899–904.
- Park HJ, Park K. Expression of Fas/APO-1 and apoto-sis of keratinocytes in human cholesteatoma. Laryngo-scope 1999; 109: 613–6.
- Gantz BJ.Epidermal Langerhans'cell incholesteatoma. Ann Otol Rhinol Laryngol 1984; 93: 150–6.
- Veldman JE, Visser CE, Schuurman HJ, DeGroot JCMJ, Huizing EH. Immunobiology of Langerhans' cells migrating into aural cholesteatomas. Otolaryngol Head Neck Surg 1984; 92: 1–6.
- Fulton C, Anderson GM, Zasloff M, Bull R, Quinn AG. Expression of natural peptide antibiotics in hu-man skin. Lancet 1997; 350: 1750–1.
- McCray Jr PB, Bentley L. Human airway epithelia express a P-defensin. Am J Respir Cell Mol Biol 1997; 16: 343–9.
- Valore EV, Park CH, Quayle AJ, Wiles KR, McCray Jr PB, Gantz T. Human P-defensin 1: an antimicrobial peptide to urogenital tissues. J Clin Invest 1998; 101: 1633–42.
- Mathews M, Jia HP, Guthmiller JM, et al. Production of P-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999; 67: 2740–5.
- Harder J, Bartels J, Christophers E, Schroeder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861–2.
- Bals R, Wang X, Wu Z, et al. Human P-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102: 874–80.
- O'Neil DA, Porter EM, Elewaut D, et al. Expression and regulation of the human P-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999; 163: 718–24.
- Boe R, Silvola J, Yang J, et al. Human 13-defensin-1 mRNA is transcribed in tympanic membrane and adja-cent auditory canal epithelium. Infect Immun 1999; 67: 4843–6.
- Moon SK, Lee HY, Li JD, et al. Activation of a Src-dependent raf-MEK 1/2-ERK signaling pathway is required for IL-la-induced upregulation of P-defensin 2 in human middle ear epithelial cells. Biochim Biophys Acta 2002; 1590: 41–51.
- Chertov 0, Michiel DF, Xu L, Wang JVV, Tani K, Murphy WJ. Identification of defensin-1, defensin-2, and CA37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neu-trophils. J Biol Chem 1996; 271: 2935–40.
- Yang D, Chertov O, Oppenheim JJ. The role of mam-malian antimicrobial peptides and proteins in awaken-ing of innate host defenses and adaptive immunity. Cell Mol Life Sci 2001; 58: 978–89.